Welcome to our dedicated page for Blackbaud news (Ticker: $BLKB), a resource for investors and traders seeking the latest updates and insights on Blackbaud stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Blackbaud's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Blackbaud's position in the market.
EVERFI from Blackbaud's Prescription Drug Safety course has been certified as meeting ESSA standards, showing a positive impact on students' knowledge of safe prescription drug use. The course helps increase personal responsibility, accurate perceptions of social norms, knowledge of prescriptions, refusal skills, and decreases likelihood of future prescription drug abuse actions.
The Blackbaud Institute released a new report, 'Gen Z at the Table,' revealing that 84% of Gen Zers support nonprofit organizations, charities, or causes in some way. The report provides insights into Gen Z philanthropic behavior, indicating a potential increase in financial donations and emphasizing the importance of trust, impact assurance, convenience, and workplace giving and volunteering. The report aims to guide professionals in effectively engaging with Gen Z donors.
Blackbaud held its Semi-Annual Product Update Briefings, unveiling hundreds of product updates and sharing roadmaps for key products, emphasizing the integration of AI to drive social impact. The company showcased enhancements for Blackbaud Raiser's Edge NXT® and Blackbaud Financial Edge NXT®. Blackbaud CRM™ will feature a new user interface in 2025, with improved accessibility and security. Updates for K-12 Education Solutions and Corporate Impact Solutions were also highlighted.
Blackbaud, a leading provider of software for social impact, announced strong 2024 Q1 results, with total revenue up 6.7% to $279.3 million and GAAP recurring revenue up 7.4% to $271.5 million. The company made progress in profitability, repurchased 5.5% of outstanding stock, and expects to achieve the Rule of 40 for the year. Non-GAAP metrics showed growth across the board, with adjusted EBITDA up 31.8% to $88.9 million. Recent highlights include share repurchases, innovation in fundraising software, a new credit facility, and success in charity fundraising events.